Colorado Medicaid Outcomes-Based Contracting Gets Green Light From CMS

State is third to obtain approval from CMS to negotiate supplemental rebates as part of value-based contract. Arrangements would be exempt from “best price” requirements.

3D illustration. Traffic light with green light on, signal open to go ahead.

Colorado’s Medicaid program is gearing up to negotiate outcomes-based contracts for prescription drugs now that the Centers for Medicare and Medicaid Services has approved its request to do so.

CMS “has approved a Colorado plan allowing the [department] to negotiate supplemental rebate agreements involving value-based contracts with pharmaceutical companies,”...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access